Chinese satellite reportedly beats Starlink by transferring data 5x faster using a tiny laser
In a pioneering advance for satellite communications, Chinese scientists have stunned the global space community by transmitting data from a staggering altitude of 36,000 kilometres using a laser no more powerful than a nightlight. This 2-watt laser, part of a cutting-edge satellite experiment, achieved an extraordinary 1 Gbps data rate, outperforming
Starlink
's network by fivefold. What makes this feat even more astonishing is that it was accomplished through Earth's turbulent atmosphere, long considered a major barrier to laser-based communications. The breakthrough could redefine how satellites are built, deployed and operated in the future of
global internet infrastructure
.
How China's 2-watt laser surpassed Starlink's speed from deep space
At the core of this technological milestone lies an incredibly low-powered 2-watt laser, about the same strength as a household LED bulb. Despite its seemingly weak output, the laser successfully beamed high-speed data across a vast 36,000 km gap, smashing expectations. This performance easily eclipses Starlink's average speeds of a few megabits per second, even though the SpaceX satellites operate at much lower orbits of around 550 km. According to reports from Interesting Engineering, the Chinese laser's data transfer was stable and fast, making it one of the most efficient space-based communication tests ever recorded.
AO-MDR synergy: China's secret weapon
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Secure Your Child's Future with Strong English Fluency
Planet Spark
Learn More
Undo
The Chinese research team, led by Professor Wu Jian of Peking University and Liu Chao from the Chinese Academy of Sciences, deployed an innovative technique known as AO-MDR synergy. This stands for adaptive optics (AO) and mode diversity reception (MDR), two complementary technologies that correct for atmospheric distortion and capture scattered laser signals. Previously, each method alone fell short of overcoming turbulence, but when combined, they delivered remarkably clear and consistent transmission even through chaotic atmospheric layers. This development could prove transformative for future satellite-to-Earth laser communication systems.
High orbit, higher rewards
Most satellite networks like Starlink operate in low Earth orbit (LEO), requiring thousands of satellites to ensure global coverage. China's breakthrough challenges that model by proving that fewer satellites positioned in higher geostationary orbits can deliver comparable or even superior results. The ability to send high-speed data over 36,000 km using low-power lasers means less dependency on bulky satellite constellations and ground infrastructure. This not only reduces launch costs and orbital congestion but also offers a more sustainable model for space-based communication.
Implications for global internet and national security
The success of this experiment isn't just a technical win, it's a strategic signal. As nations race to dominate the next era of digital infrastructure, China's leap forward showcases its growing influence in the space-tech sector. High-speed, laser-based satellite communication could reshape how rural areas connect to the internet, how disaster relief is coordinated, and how governments ensure secure data transmission. Moreover, fewer satellites at higher altitudes mean less risk of space debris and potentially safer, longer-lasting networks.
This achievement offers a glimpse into the future of laser-powered satellite communications. If scaled successfully, AO-MDR synergy could pave the way for a global internet that's faster, cleaner and more reliable. China's bold step may not just change the rules of space communication, it could rewrite them entirely. Whether this spurs global collaboration or fuels further competition, one thing is clear: the skies are no longer the limit.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
18 minutes ago
- Time of India
Why Tesla's robotaxi launch was the easy part
HighlightsTesla has deployed its first-ever driverless taxis in Austin, Texas, marking a small-scale test of its Model Y vehicles, while facing significant challenges in expanding its autonomous driving software rapidly across millions of vehicles within a year. Despite Tesla's advantages in mass manufacturing and remote software updates, experts caution that the company may struggle to refine its technology to handle complex traffic scenarios, potentially undermining public trust in autonomous vehicles. The company's recent robotaxi test revealed safety concerns, as one passenger documented a vehicle entering the wrong lane at an intersection, highlighting the ongoing challenges Tesla faces in achieving fully autonomous driving capabilities. Tesla finally has a robotaxi . Now comes the hard part. The electric-vehicle maker deployed its first-ever driverless cabs in Austin, Texas, on Sunday in a small-scale test of carefully monitored Model Y vehicles. Next, the company faces the steep challenge of executing on CEO Elon Musk's ambition to refine the software and upload it to millions of Teslas within a year or so. Such a rapid expansion will prove extremely difficult, about a dozen industry analysts and autonomous-vehicle technology experts told Reuters. These observers expressed a range of views about Tesla's prospects but all cautioned against assuming a light-speed robotaxi rollout. Some pointed to advantages Tesla might exploit to overtake rivals including Alphabet's Waymo and a host of Chinese auto and tech companies. Tesla has mass-manufacturing capacity, and it pioneered remote software updates it can use for self-driving upgrades. The automaker also does not use sensors such as radar and lidar like Waymo and most rivals; instead, it depends solely on cameras and artificial intelligence. 'A rollout could be really quick. If the software works, Tesla robotaxi could drive any road in the world,' said Seth Goldstein, a Morningstar senior equity analyst, while cautioning that Tesla is still 'testing the product.' In Austin, Tesla launched a choreographed experiment involving maybe a dozen cars, operating in limited geography, with safety monitors in the front passenger seat; remote 'teleoperators'; plans to avoid bad weather; and hand-picked pro-Tesla influencers as passengers. For years, Musk has said Tesla would soon operate its own autonomous ride-hailing service and also turn any Tesla, new or used, into a cash-generating robotaxi for its customers. That will be 'orders of magnitude' more difficult than testing in Austin, said Bryant Walker Smith , a University of South Carolina law professor focused on autonomous-driving regulation. 'It's like announcing that, 'I'm going to Mars' and then, you know, going to Cleveland,' Smith said. Musk has said Tesla will reach Mars, in that metaphor, quite quickly: "I predict that there will be millions of Teslas operating fully autonomously in the second half of next year," he said in April. Musk and Tesla did not respond to requests for comment. Tesla shares ended 8.2% higher at $348.68 on Monday on investor enthusiasm over the robotaxi launch. Given Tesla's AI-dependent approach, its challenge will be machine-training robotaxis to handle complex traffic 'edge cases,' said Philip Koopman, a Carnegie Mellon University computer-engineering professor and autonomous-technology expert. That could take many years. 'Look, how long has it taken Waymo?' Koopman asked. 'There's no reason to believe Tesla will be any faster.' LONG SLOG Waymo's self-driving efforts date back to 2009, when Google started its self-driving car project. An egg-shaped prototype took its first ride on public streets in 2015 – also in Austin. Waymo has taken since then to build a 1,500-robotaxi fleet in select cities. A Waymo spokesperson said it plans to add 2,000 more vehicles by the end of 2026. Some analysts believe Tesla can expand faster, in part because Waymo has helped pave the way by overcoming regulatory and technical challenges. 'Waymo and other pioneers have helped to drive regulatory change and have made riders, pedestrians and other road users aware of autonomous vehicles,' said Paul Miller, an analyst at market-research firm Forrester. Being a mass-manufacturer also helps Tesla, Miller said. Waymo buys Jaguar I-PACE SUVs and outfits them with more expensive sensors and technology than Tesla integrates into its vehicles. Waymo declined to comment on Tesla's robotaxi-expansion potential. The company's former CEO, John Krafcik , remains skeptical. The precautions Tesla employed in Austin reveal it does not have confidence its technology is safe at scale, Krafcik said. 'And they shouldn't,' he said. 'It's not as safe as it needs to be, and falls well short of the robust approach and well-documented safety that Waymo has demonstrated.' 'WRONG SIDE' OF THE ROAD Tesla's go-fast strategy could actually slow its progress and that of the autonomous-vehicle industry if it undermines public trust, some analysts said. Tesla has historically faced legal and regulatory trouble involving its Full Self-Driving (FSD) driver-assistance system, which is not fully autonomous. In one recent federal safety probe into Tesla, investigators are examining FSD's role in crashes – some fatal – involving rain or other inclement weather that interferes with the system's cameras. Before the Austin test, Musk posted on his social-media platform, X, that the robotaxis' technology would differ little from any Tesla, aside from a software update: 'These are unmodified Tesla cars coming straight from the factory, meaning that every Tesla,' he wrote, 'is capable of unsupervised self-driving!' The automaker invited Tesla-friendly influencers to take its first robotaxi rides, and they generally cheered the experience. One social-media video posted by a robotaxi passenger, however, showed the vehicle proceeding through a four-lane intersection with a traffic light – and into the wrong lane, for about six seconds. No oncoming traffic was in the lane at the time. 'Obviously we're on the wrong side of the double-yellow line here,' said the passenger, Rob Maurer, in a video narration of the experience he posted on X, noting that he felt safe but that the car behind him honked at the 'confusing maneuver." Maurer did not respond to requests for comment. Reuters verified the location of the video by matching the surrounding buildings, business and street signs to the intersection of West Riverside Drive and Barton Springs Road in Austin. Separately, a Reuters witness followed another Tesla robotaxi and measured its speed as it traveled at between 40 and 45 mph in a 35 mph zone on First Street, adjacent to the Texas School for the Deaf . A sign warned to watch for deaf pedestrians.
Time of India
20 minutes ago
- Time of India
Scorpion venom offers new hope for breast cancer patients: Study
Source: NFCR In a breakthrough, Brazilian scientists have found a molecule in an Amazonian scorpion venom with great potential to cure the widely spreading cancer. The research conducted by the team at the University of São Paulo and presented during FAPESP Week France details how the natural compound can lead to alternative cancer treatments. As per the research, the venom of the scorpion seems to attack and kill cancer cells with little destruction to normal tissue. This research can pave the way to hopeful prospects for the creation of new treatments from nature, promising better and less invasive therapies for breast cancer in the future. Scorpion venom molecule found to kill breast cancer cells in early tests The focus of the study is a molecule named BamazScplp1, extracted from the venom of the Brotheas amazonicus scorpion. Early laboratory tests revealed that this peptide can kill breast cancer cells like paclitaxel, one of the most widely used chemotherapy drugs. 'Through bioprospecting, we were able to identify a molecule in this species of Amazonian scorpion that acts against breast cancer cells,' said Professor Eliane Candiani Arantes, coordinator of the project. The molecule belongs to the family of serine proteases, enzymes known for their ability to break down proteins and potentially disrupt the life cycle of cancer cells. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like TVS Serene Springs | Senior Citizen Homes In OMR, Chennai. TVS Emerald Learn More Undo Tests conducted on breast cancer cells showed that BamazScplp1 induces cell death primarily through necrosis, a process in which cells break apart uncontrollably. While necrosis is often considered a damaging form of cell death in healthy tissues, in cancer therapy, it can be highly effective when used to target tumors. The response was comparable to that triggered by paclitaxel, suggesting that BamazScplp1 may offer similar therapeutic effects. 'The peptide induces cell death mainly through necrosis, an action similar to that of molecules identified in other scorpion species,' the study reported. Scientists use yeast to mass produce cancer fighting molecule Instead of collecting venom directly from scorpions, the researchers turned to a bioengineering method called heterologous expression. This involves inserting the gene that codes for the target protein into a host organism commonly yeast or bacteria which then produces the protein in large amounts. 'We intend to obtain these molecules through heterologous expression,' Professor Arantes explained. The team plans to use Pichia pastoris, a yeast strain often employed in biotechnology, to mass-produce the peptide for further research and testing. This method eliminates the need for scorpion venom extraction, making it both ethical and scalable two critical factors for future drug development. Global burden of breast cancer Breast cancer is the leading diagnosed cancer in women and the second most prevalent cancer globally, according to the World Health Organization (WHO). A 2024 Nature Medicine study estimated that an estimated 1 in 20 women worldwide will develop breast cancer in their lifetime. In 2022 alone, there were an estimated 2.3 million new breast cancer diagnoses worldwide, and about 670,000 deaths. Most cases (71%) and fatalities (79%) were in people over the age of 50. If current trends persist, breast cancer diagnoses worldwide are likely to increase to 3.2 million a year by 2050, with more than 1 million deaths a year. Scorpion molecule could be a game-changer in breast cancer treatment Though these results are preliminary, they underscore the promise of natural products in the drug development process. Further lab work, animal testing, and eventually human clinical trials will be needed to establish if BamazScplp1 can safely and effectively be utilized in humans. If it is proven effective, the molecule has the potential to lead to a new generation of cancer treatments based on nature, bringing hope to millions of breast cancer sufferers worldwide. Also Read | Meet Jahnavi Dangeti, NASA's first Indian IASP graduate from Andhra Pradesh set for 2029 space mission
Time of India
23 minutes ago
- Time of India
Israel killed at least 14 scientists in an unprecedented attack on Iran's nuclear know-how
Israel 's tally of the war damage it wrought on Iran includes the targeted killings of at least 14 scientists, an unprecedented attack on the brains behind Iran's nuclear program that outside experts say can only set it back, not stop it. In an interview with The Associated Press, Israel's ambassador to France said the killings will make it "almost" impossible for Iran to build weapons from whatever nuclear infrastructure and material may have survived nearly two weeks of Israeli airstrikes and massive bunker-busting bombs dropped by U.S. stealth bombers. "The fact that the whole group disappeared is basically throwing back the program by a number of years, by quite a number of years," Ambassador Joshua Zarka said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Monitor Temperature Easily [Get Started] Warehouse Temperature | Search Ads Read More Undo But nuclear analysts say Iran has other scientists who can take their place. European governments say that military force alone cannot eradicate Iran's nuclear know-how, which is why they want a negotiated solution to put concerns about the Iranian program to rest. "Strikes cannot destroy the knowledge Iran has acquired over several decades, nor any regime ambition to deploy that knowledge to build a nuclear weapon," U.K. Foreign Secretary David Lammy told lawmakers in the House of Commons . Live Events Here's a closer look at the killings: Chemists, physicists, engineers among those killed Zarka told AP that Israeli strikes killed at least 14 physicists and nuclear engineers, top Iranian scientific leaders who "basically had everything in their mind." They were killed "not because of the fact that they knew physics, but because of the fight that they were personally involved in, the creation and the fabrication and the production of (a) nuclear weapon," he said. Nine of them were killed in Israel's opening wave of attacks on June 13, the Israeli military said. It said they "possessed decades of accumulated experience in the development of nuclear weapons" and included specialists in chemistry, materials and explosives as well as physicists. Targeted killings meant to discourage would-be successors Experts say that decades of Iranian work on nuclear energy - and, Western powers allege, nuclear weapons - has given the country reserves of know-how and scientists who could continue any work toward building warheads to fit on Iran's ballistic missiles. "Blueprints will be around and, you know, the next generation of Ph.D. students will be able to figure it out," said Mark Fitzpatrick, who specialized in nuclear non-proliferation as a former U.S. diplomat. Bombing nuclear facilities "or killing the people will set it back some period of time. Doing both will set it back further, but it will be reconstituted." "They have substitutes in maybe the next league down, and they're not as highly qualified, but they will get the job done eventually," said Fitzpatrick, now an analyst at the International Institute for Strategic Studies , a London think tank. How quickly nuclear work could resume will in part depend on whether Israeli and U.S. strikes destroyed Iran's stock of enriched uranium and equipment needed to make it sufficiently potent for possible weapons use. "The key element is the material. So once you have the material, then the rest is reasonably well-known," said Pavel Podvig, a Geneva-based analyst who specializes in Russia's nuclear arsenal. He said killing scientists may have been intended "to scare people so they don't go work on these programs." "Then the questions are, 'Where do you stop?' I mean you start killing, like, students who study physics?" he asked. "This is a very slippery slope." The Israeli ambassador said: "I do think that people that will be asked to be part of a future nuclear weapon program in Iran will think twice about it." Previous attacks on scientists Israel has previously long been suspected of killing Iranian nuclear scientists but didn't claim responsibility as it did this time. In 2020, Iran blamed Israel for killing its top nuclear scientist, Mohsen Fakhrizadeh, with a remote-controlled machine gun. "It delayed the program but they still have a program. So it doesn't work," said Paris-based analyst Lova Rinel, with the Foundation for Strategic Research think tank. "It's more symbolic than strategic." Without saying that Israel killed Fakhrizadeh, the Israeli ambassador said "Iran would have had a bomb a long time ago" were it not for repeated setbacks to its nuclear program - some of which Iran attributed to Israeli sabotage. "They have not reached the bomb yet," Zarka said. "Every one of these accidents has postponed a little bit the program." A legally grey area International humanitarian law bans the intentional killing of civilians and non-combatants. But legal scholars say those restrictions might not apply to nuclear scientists if they were part of the Iranian armed forces or directly participating in hostilities. "My own take: These scientists were working for a rogue regime that has consistently called for the elimination of Israel, helping it to develop weapons that will allow that threat to take place. As such, they are legitimate targets," said Steven R. David, a professor of political science at Johns Hopkins University . He said Nazi German and Japanese leaders who fought Allied nations during World War II "would not have hesitated to kill the scientists working on the Manhattan Project" that fathered the world's first atomic weapons. Laurie Blank, a specialist in humanitarian law at Emory Law School, said it's too early to say whether Israel's decapitation campaign was legal. "As external observers, we don't have all the relevant facts about the nature of the scientists' role and activities or the intelligence that Israel has," she said by email to AP. "As a result, it is not possible to make any definitive conclusions." Zarka, the ambassador, distinguished between civilian nuclear research and the scientists targeted by Israel. "It's one thing to learn physics and to know exactly how a nucleus of an atom works and what is uranium," he said. But turning uranium into warheads that fit onto missiles is "not that simple," he said. "These people had the know-how of doing it, and were developing the know-how of doing it further. And this is why they were eliminated."
